Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System
Launched by THE CLEVELAND CLINIC · Apr 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the outcomes of a special knee device called the Triathlon Hinge Knee System, which is used for patients undergoing knee surgery, either for the first time or as a follow-up to a previous surgery. The main goal is to see how well this device works over time, specifically in helping patients recover from knee problems, including arthritis or infections. The study will gather information about patients’ backgrounds, details about their surgeries, and their recovery progress at different stages, including 1, 2, 6, and 10 years after the surgery.
To take part in this study, participants need to be adults who are having surgery that includes the Triathlon Hinge Knee device, and they must agree to follow the study's guidelines. However, individuals with certain conditions, like active infections in the knee or severe instability, cannot join. If you or someone you know is considering this surgery and meets the eligibility criteria, you can expect close monitoring of your recovery and the chance to contribute to important research that may help improve knee treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The subject undergoes a primary or revision procedure implanting at least the Revision Baseplate portion of the Triathlon Hinge Knee System in accordance with the Indications for Use.
- • The subject has signed an IRB/EC-approved, study-specific Informed Consent Form (ICF).
- • The subject is a male or non-pregnant female at the time of enrollment.
- • The subject agrees to comply with the protocol-mandated clinical evaluations.
- Exclusion Criteria:
- • Any active or suspected latent infection in or about the knee joint; overt infection;
- • Distant foci of infection which may cause hematogenous spread to the implant site; rapid disease progression as manifested by joint destruction or bone resorption apparent on roentgenogram;
- • skeletally immature patients;
- • Severe instability of the knee joint secondary to the absence of collateral ligament integrity and function.
- • Bone stock compromised by disease, infection or prior implantation which cannot provide adequate support and/or fixation to the prosthesis.
- • Known or suspected sensitivity and/or allergy to any material in the device.
- * Conditions presenting an increased risk of failure include:
- • uncooperative patient or patient with neurologic disorder, incapable of following instructions;
- • osteoporosis;
- • metabolic disorders which may impair bone formation or cause bone loss;
- • osteomalacia; and,
- • previous arthrodesis.
- • A higher incidence of implant failure has also occurred in paraplegics, cerebral palsy and patients with Parkinson's disease.
- • Any mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care.
- • The subject is a prisoner
About The Cleveland Clinic
The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Cleveland, Ohio, United States
Weston, Florida, United States
Patients applied
Trial Officials
Matthew Deren, M.D.
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported